Transcriptomic profile of ataxia telangiectasia cells treated for 30 days with a low dose of dexamethasone

References

• Abraham RT. 2001. Cell cycle checkpoint signaling through the atm and atr kinases. Genes Dev. 15:2177–2196.
   PubMed Web of Science ®Google Scholar
• Abraham RT. 2004. Pi 3-kinase related kinases: ‘big’ players in stress-induced signaling pathways. DNA Repair. 3:883–887.
   PubMed Web of Science ®Google Scholar
• Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, Inoki K, Guan KL, Shen J, Person MD, et al. 2010. Atm signals to tsc2 in the cytoplasm to regulate mtorc1 in response to ros. Proc Natl Acad Sci USA. 107:4153–4158.
   PubMed Web of Science ®Google Scholar
• Alexander A, Kim J, Walker CL. 2010. Atm engages the tsc2/mtorc1 signaling node to regulate autophagy. Autophagy. 6:672–673.
   PubMed Web of Science ®Google Scholar
• Bakkenist CJ, Kastan MB. 2003. DNA damage activates atm through intermolecular autophosphorylation and dimer dissociation. Nature. 421:499–506.
   PubMed Web of Science ®Google Scholar
• Biton S, Barzilai A, Shiloh Y. 2008. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle. DNA Repair. 7:1028–1038.
   PubMed Web of Science ®Google Scholar
• Broccoletti T, Del Giudice E, Amorosi S, Russo I, Di Bonito M, Imperati F, Romano A, Pignata C. 2008. Steroid-induced improvement of neurological signs in ataxia-telangiectasia patients. Eur J Neurol. 15:223–228.
   PubMed Web of Science ®Google Scholar
• Buccitelli C, Selbach M. 2020. Mrnas, proteins and the emerging principles of gene expression control. Nat Rev Genet. 21:630–644.
   PubMed Web of Science ®Google Scholar
• Buoni S, Zannolli R, Sorrentino L, Fois A. 2006. Betamethasone and improvement of neurological symptoms in ataxia-telangiectasia. Arch Neurol. 63:1479–1482.
   PubMedGoogle Scholar
• Cam H, Easton JB, High A, Houghton PJ. 2010. Mtorc1 signaling under hypoxic conditions is controlled by atm-dependent phosphorylation of hif-1alpha. Mol Cell. 40:509–520.
   PubMed Web of Science ®Google Scholar
• Chessa L, Leuzzi V, Plebani A, Soresina A, Micheli R, D’Agnano D, Venturi T, Molinaro A, Fazzi E, Marini M, et al. 2014. Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial. Orphanet. J. Rare. Dis. 9:5. doi: 10.1186/1750-1172-9-5.
   PubMed Web of Science ®Google Scholar
• Choy KR, Watters DJ. 2018. Neurodegeneration in ataxia-telangiectasia: multiple roles of atm kinase in cellular homeostasis. Dev Dyn. 247:33–46.
   PubMed Web of Science ®Google Scholar
• Chun HH, Gatti RA. 2004. Ataxia-telangiectasia, an evolving phenotype. DNA Repair. 3:1187–1196.
   PubMed Web of Science ®Google Scholar
• Coker SA, Szczepiorkowski ZM, Siegel AH, Ferrari A, Mambrini G, Anand R, Hartman RD, Benatti L, Dumont LJ. 2018. A study of the pharmacokinetic properties and the in vivo kinetics of erythrocytes loaded with dexamethasone sodium phosphate in healthy volunteers. Transfus Med Rev. 32:102–110.
   PubMed Web of Science ®Google Scholar
• Dammann CE, Nassimi N, Liu W, Nielsen HC. 2006. Erbb receptor regulation by dexamethasone in mouse type ii epithelial cells. Eur Respir J. 28:1117–1123.
   PubMed Web of Science ®Google Scholar
• D’Assante R, Fusco A, Palamaro L, Polishchuk E, Polishchuk R, Bianchino G, Grieco V, Prencipe MR, Ballabio A, Pignata C. 2017. Abnormal cell-clearance and accumulation of autophagic vesicles in lymphocytes from patients affected with ataxia-teleangiectasia. Clin Immunol. 175:16–25.
   Web of Science ®Google Scholar
• Freen-van Heeren JJ, Nicolet BP, Wolkers MC. 2020. Combined single-cell measurement of cytokine mrna and protein in immune cells. Methods Mol Biol. 2108:259–271.
   Google Scholar
• Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, Foroud T, Jaspers NG, Lange K, et al. 1988. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature. 336:577–580.
   PubMed Web of Science ®Google Scholar
• Gilad S, Chessa L, Khosravi R, Russell P, Galanty Y, Piane M, Gatti RA, Jorgensen TJ, Shiloh Y, Bar-Shira A. 1998. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet. 62:551–561.
   PubMed Web of Science ®Google Scholar
• Grbesa I, Hakim O. 2017. Genomic effects of glucocorticoids. Protoplasma. 254:1175–1185.
   Web of Science ®Google Scholar
• Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. 2010. Atm activation by oxidative stress. Science. 330:517–521.
   PubMed Web of Science ®Google Scholar
• Guo QQ, Wang SS, Zhang SS, Xu HD, Li XM, Guan Y, Yi F, Zhou TT, Jiang B, Bai N, et al. 2020. Atm-chk2-beclin 1 axis promotes autophagy to maintain ros homeostasis under oxidative stress. EMBO J. 39(10):e103111. doi:10.15252/embj.2019103111.
   PubMed Web of Science ®Google Scholar
• Kozlov SV, Graham ME, Peng C, Chen P, Robinson PJ, Lavin MF. 2006. Involvement of novel autophosphorylation sites in atm activation. EMBO J. 25:3504–3514.
   PubMed Web of Science ®Google Scholar
• Lavin MF. 2008. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol. 9:759–769.
   PubMed Web of Science ®Google Scholar
• Leuzzi V, D’Agnano D, Menotta M, Caputi C, Chessa L, Magnani M. 2018. Ataxia-telangiectasia: A new remitting form with a peculiar transcriptome signature. Neurol Genet. 4(2):e228. doi: 10.1212/NXG.0000000000000228.
   Web of Science ®Google Scholar
• Leuzzi V, Micheli R, D’Agnano D, Molinaro A, Venturi T, Plebani A, Soresina A, Marini M, Ferremi Leali P, Quinti I, et al. 2015. Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia. Neurol – Neuroimmunol Neuroinflammation. 2(3):e98. doi: 10.1212/NXI.0000000000000098.
   Web of Science ®Google Scholar
• Menotta M, Biagiotti S, Bartolini G, Marzia B, Orazi S, Germani A, Chessa L, Magnani M. 2017. Nano-mechanical characterization of ataxia telangiectasia cells treated with dexamethasone. Cell Biochem Biophys. 75:95–102.
   PubMed Web of Science ®Google Scholar
• Menotta M, Biagiotti S, Bianchi M, Chessa L, Magnani M. 2012. Dexamethasone partially rescues ataxia telangiectasia-mutated (atm) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity. J Biol Chem. 287:41352–41363.
   PubMed Web of Science ®Google Scholar
• Menotta M, Biagiotti S, Orazi S, Rossi L, Chessa L, Leuzzi V, D’Agnano D, Plebani A, Soresina A, Magnani M. 2018. In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia. Mol Cell Biochem. 438:153–166.
   Web of Science ®Google Scholar
• Menotta M, Biagiotti S, Spapperi C, Orazi S, Rossi L, Chessa L, Leuzzi V, D’Agnano D, Soresina A, Micheli R, et al. 2017. Atm splicing variants as biomarkers for low dose dexamethasone treatment of a-t. Orphanet J Rare Dis. 12(1):126. doi: 10.1186/s13023-017-0669-2.
   PubMedGoogle Scholar
• Menotta M, Orazi S, Gioacchini AM, Spapperi C, Ricci A, Chessa L, Magnani M. 2018. Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with dexamethasone. PloS One. 13(4):e0195388. doi: 10.1371/journal.pone.0195388.
   Web of Science ®Google Scholar
• Mitre-Aguilar IB, Cabrera-Quintero AJ, Zentella-Dehesa A. 2015. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer. Int J Clin Exp Pathol. 8:1–10.
   PubMed Web of Science ®Google Scholar
• Paakinaho V, Johnson TA, Presman DM, Hager GL. 2019. Glucocorticoid receptor quaternary structure drives chromatin occupancy and transcriptional outcome. Genome Res. 29:1223–1234.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time rt-pcr. Nucleic Acids Res. 29(9):e45. doi: 10.1093/nar/29.9.e45.
   PubMed Web of Science ®Google Scholar
• Prencipe R, Cirillo E, Giardino G, Gallo V, Menotta M, Magnani M, Barone MV, Palamaro L, Scalia G, Del Vecchio L, et al. 2020. In ataxia-telangiectasia, oral betamethasone administration ameliorates lymphocytes functionality through modulation of the il-7/il-7ralpha axis paralleling the neurological behavior: A comparative report of two cases. Immunol Investig. 50(2-3):295–303.
   Web of Science ®Google Scholar
• Ricci A, Galluzzi L, Magnani M, Menotta M. 2020. Ddit4 gene expression is switched on by a new hdac4 function in ataxia telangiectasia. FASEB J. 34:1802–1818.
   Web of Science ®Google Scholar
• Sarkar A, Stellrecht CM, Vangapandu HV, Ayres M, Kaipparettu BA, Park JH, Balakrishnan K, Burks JK, Pandita TK, Hittelman WN, et al. 2020. Ataxia telangiectasia mutated interacts with parkin and induces mitophagy independent of kinase activity. evidence from mantle cell lymphoma. Haematologica. 106(2):495–512.
   Web of Science ®Google Scholar
• Scheving LA, Buchanan R, Krause MA, Zhang X, Stevenson MC, Russell WE. 2007. Dexamethasone modulates erbb tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes. Am J Physiol-Gastrointestinal Liver Physiol. 293:G552–G559.
   PubMed Web of Science ®Google Scholar
• Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. 2011. Global quantification of mammalian gene expression control. Nature. 473:337–342.
   PubMed Web of Science ®Google Scholar
• Sharma NK, Lebedeva M, Thomas T, Kovalenko OA, Stumpf JD, Shadel GS, Santos JH. 2014. Intrinsic mitochondrial DNA repair defects in ataxia telangiectasia. DNA Repair. 13:22–31.
   PubMed Web of Science ®Google Scholar
• Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative rt-pcr data by geometric averaging of multiple internal control genes. Genome Biol. 3(7):0034.1–0034.11. doi: 10.1186/gb-2002-3-7-research0034.
   Web of Science ®Google Scholar
• van Os NJH, Jansen AFM, van Deuren M, Haraldsson A, van Driel NTM, Etzioni A, van der Flier M, Haaxma CA, Morio T, Rawat A, et al. 2017. Ataxia-telangiectasia: immunodeficiency and survival. Clin Immunol. 178:45–55.
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Schlegl J, Hahne H, Gholami AM, Lieberenz M, Savitski MM, Ziegler E, Butzmann L, Gessulat S, Marx H, et al. 2014. Mass-spectrometry-based draft of the human proteome. Nature. 509:582–587.
   PubMed Web of Science ®Google Scholar
• Winer J, Jung CK, Shackel I, Williams PM. 1999. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal.Biochem. 270:41–49.
   PubMed Web of Science ®Google Scholar
• Wu G, Feng X, Stein L. 2010. A human functional protein interaction network and its application to cancer data analysis. Genome Biol. 11(5):R53. doi: 10.1186/gb-2010-11-5-r53.
   PubMed Web of Science ®Google Scholar
• Yan M, Kuang X, Scofield VL, Shen J, Lynn WS, Wong PK. 2007. The glucocorticoid receptor is increased in atm-/- thymocytes and in atm-/- thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression. Steroids. 72:415–421.
   PubMed Web of Science ®Google Scholar
• Yang DQ, Kastan MB. 2000. Participation of atm in insulin signalling through phosphorylation of eif-4e-binding protein 1. Nat Cell Biol. 2:893–898.
   PubMed Web of Science ®Google Scholar
• Zannolli R, Buoni S, Betti G, Salvucci S, Plebani A, Soresina A, Pietrogrande MC, Martino S, Leuzzi V, Finocchi A, et al. 2012. A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia. Mov Disord. 27:1312–1316.
   PubMed Web of Science ®Google Scholar
• Zheng C, Zhou Y, Huang Y, Chen B, Wu M, Xie Y, Chen X, Sun M, Liu Y, Chen C, et al. 2019. Effect of atm on inflammatory response and autophagy in renal tubular epithelial cells in lps-induced septic aki. Exp Ther Med. 18:4707–4717.
   PubMed Web of Science ®Google Scholar